GLP-1-based pancreatic gene therapy maintained weight loss after semaglutide withdrawal in rodents
Fractyl Health has revealed that preclinical findings from its Rejuva gene therapy platform, presented at the World Congress Insulin...
GLP-1-based pancreatic gene therapy maintained weight loss after semaglutide withdrawal in rodents
GIP receptors profoundly impact metabolism and weight regulation
How GLP-1s and RAGE control diabetic kidney damage
Levita Magnetics reveals first international deployment of MARS Surgical System
Bariatric patients have lower pregnancy weight gain vs non-surgical controls
Factors associated with long-term use of FDA-approved anti-obesity medications
Zepbound (tirzepatide) available in US pharmacies for adults living with obesity